X-8570498-C-G
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000216.4(ANOS1):c.1062+1G>C variant causes a splice donor, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000216.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- hypogonadotropic hypogonadism 1 with or without anosmiaInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
- Kallmann syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000216.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ANOS1 | NM_000216.4 | MANE Select | c.1062+1G>C | splice_donor intron | N/A | NP_000207.2 | |||
| ANOS1 | NM_001440775.1 | c.1062+1G>C | splice_donor intron | N/A | NP_001427704.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ANOS1 | ENST00000262648.8 | TSL:1 MANE Select | c.1062+1G>C | splice_donor intron | N/A | ENSP00000262648.3 | |||
| ANOS1 | ENST00000488294.1 | TSL:2 | n.152+1G>C | splice_donor intron | N/A |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Hypogonadotropic hypogonadism 1 with or without anosmia Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. Disruption of this splice site has been observed in individuals with Kallmann syndrome (PMID: 16882753, 31200363). This variant is not present in population databases (gnomAD no frequency). This sequence change affects a donor splice site in intron 7 of the ANOS1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in ANOS1 are known to be pathogenic (PMID: 8504298, 11297579).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at